JointHealth™ express May 31, 2023
In this issue of JointHealth™ insight, Arthritis Consumer Experts (ACE) takes a deeper look at the long and winding road towards drug development, review, and public reimbursement in Canada. The drug review process in Canada is designed to ensure that pharmaceutical manufacturers bring their new medications to market in a safe, effective and cost-effective manner. This issue will discuss the following:
Click here to download the “Canadian drug review process at a glance” infographic.
In this issue of JointHealth™ insight, Arthritis Consumer Experts (ACE) takes a deeper look at the long and winding road towards drug development, review, and public reimbursement in Canada. The drug review process in Canada is designed to ensure that pharmaceutical manufacturers bring their new medications to market in a safe, effective and cost-effective manner. This issue will discuss the following:
- The phases of drug development: Discovery and development
- The drug review process
- Inflammatory arthritis patient’s issues with drug plan reimbursement process
Click here to download the “Canadian drug review process at a glance” infographic.
Arthritis Consumer Experts
ACE thanks Arthritis Research Canada (ARC) for its scientific review of ACE and JointHealth™ information and education programs.